Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing Trends of Minimal Residual Disease Measurement in Trials Focusing on Multiple Myeloma Treatment: A Systematic Analysis of Clinical Research Design From 2014 to 2025.

European journal of haematology·2026
Same author

Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial.

European journal of haematology·2025
Same author

Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Journal of hematology & oncology·2025
Same author

Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Journal of hematology & oncology·2024
Same author

Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation.

JCO precision oncology·2024
Same journal

Model-based quantification of protein-protein interaction aberrations for exploring dysregulated signalling pathways through pathway maps and gene expression levels.

BMC bioinformatics·2026
Same journal

Research on multi-trait genome association study method based on Shannon information entropy.

BMC bioinformatics·2026
Same journal

A multi-view feature fusion framework with interpretable graph convolution for predicting microbe-drug associations.

BMC bioinformatics·2026
Same journal

Covariance decomposition for distance based species tree estimation.

BMC bioinformatics·2026
Same journal

SNPio: a Python interface for population genomic data processing.

BMC bioinformatics·2026
Same journal

SpaHNR: a spatial domain identification method via sparse attention-based hierarchical node representation and multi-view contrastive learning.

BMC bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Jul 8, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments.

Thierry Rème1, Dirk Hose, John De Vos

  • 1INSERM, U847, 99 rue Puech Villa, 34197 Montpellier, France. reme@montp.inserm.fr

BMC Bioinformatics
|January 15, 2008
PubMed
Summary
This summary is machine-generated.

A new method using Affymetrix detection calls predicts patient classification from microarray data. This approach effectively classifies multiple myeloma patient groups and predicts clinical features, offering a powerful tool for diagnostic and prognostic applications.

More Related Videos

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
03:37

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets

Published on: March 1, 2024

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jul 8, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
03:37

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets

Published on: March 1, 2024

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Area of Science:

  • Bioinformatics
  • Genomics
  • Medical Informatics

Background:

  • Microarray data analysis faces challenges due to evolving technology, hindering data integration for class prediction.
  • Affymetrix technology offers quantitative signals and detection calls, but integrating data across different chip types is difficult.
  • A new prediction method was developed using only detection calls from recent Affymetrix chip types for improved class prediction.

Purpose of the Study:

  • To develop a novel prediction method for class belonging based on Affymetrix detection calls.
  • To apply the method to biological data from normal B cells and multiple myeloma (MM) patient groups.
  • To evaluate the method's performance in predicting clinical features and compare it with existing methods.

Main Methods:

  • A call-based data reduction step filtered non-class-discriminative probe sets.
  • A predictor was developed with correction for multiple testing via iterative probe set deletion.
  • Error rates were determined using leave-one-out and 5-fold cross-validation.

Main Results:

  • The method successfully predicted patient sex, classifying gender with high accuracy across different groups.
  • Immunoglobulin light and heavy chains expressed by malignant myeloma clones were accurately predicted.
  • The method demonstrated superior performance compared to the Prediction Analysis of Microarray (PAM) method.

Conclusions:

  • The normalization-free method is valuable for quality control and correcting errors in patient reports.
  • The method is extendable to multiple class predictions for clinical groups and international projects.
  • It serves as a powerful tool for mining published Affymetrix data and classifying samples with binary features.